Anthony Viste

Dr. Anthony Viste


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2015 in International Orthopaedics
Verified
Journal Article
Closed access
PDF file
TVThibault Vermersch
Thibault Vermersch
AVAnthony Viste
Anthony Viste
RDRomain Desmarchelier
Romain Desmarchelier
MFMichel-Henri Fessy
Michel-Henri Fessy

8 December 2016 in International Orthopaedics
Verified
Journal Article
Closed access
PDF file
AVAnthony Viste
Anthony Viste
RDRomain Desmarchelier
Romain Desmarchelier
MFMichel-Henri Fessy
Michel-Henri Fessy

1 December 2017 in The Journal of Arthroplasty
Verified
Journal Article
Closed access
AVAnthony Viste
Anthony Viste
MAMatthew P. Abdel
Matthew P. Abdel
MOMatthieu Ollivier
Matthieu Ollivier
KMKristin C. Mara
Kristin C. Mara
AKAaron Krych
Aaron Krych
DBDaniel J. Berry
Daniel J. Berry

1 November 2017 in Orthopaedics & Traumatology: Surgery & Research
Verified
Journal Article
Closed access
LLL. Louboutin
L. Louboutin
AVAnthony Viste
Anthony Viste
RDR. Desmarchelier
R. Desmarchelier
MFM.-H. Fessy
M.-H. Fessy

1 September 2015 in Foot and Ankle Surgery
Verified
Journal Article
Closed access
AVAnthony Viste
Anthony Viste
NZNader AL Zahrani
Nader AL Zahrani
NBNuno Brito
Nuno Brito
CLChristophe Lienhart
Christophe Lienhart
MFMichel Henri Fessy
Michel Henri Fessy
JBJean-Luc Besse
Jean-Luc Besse

2 December 2020 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
MAMatthew P. Abdel
Matthew P. Abdel
CWCody C Wyles
Cody C Wyles
AVAnthony Viste
Anthony Viste
KPKevin I. Perry
Kevin I. Perry
RTRobert T. Trousdale
Robert T. Trousdale
DBDaniel J. Berry
Daniel J. Berry
Background: Extended trochanteric osteotomies (ETOs) provide wide femoral and acetabular exposure, give direct access to the femoral medullary canal, and facilitate implant removal and new implant placement during selected revision total hip arthroplasties (THAs). Previous studies are limited by modest patient numbers and limited length of follow-up. The goals of the current study were to assess the union rate, complications, and outcomes of contemporary ETOs performed during revision THAs. Methods: From 2003 to 2013, 612 ETOs were performed during revision THAs at 1 institution using 2 techniques: Paprosky (laterally based osteotomy; n = 367) and Wagner (anteriorly based osteotomy; n = 245). The indications for the revision procedures were aseptic loosening (65%), periprosthetic joint infection (18%), periprosthetic fracture (6%), femoral implant fracture (5%), and other (6%). The mean patient age was 69 years, and 57% of the patients were male. The mean number of previous THAs was 1.6. The median duration of follow-up was 5 years (range, 2 to 13 years). Results: The mean Harris hip scores increased from 57 preoperatively to 77 at the latest follow-up (p < 0.001). Radiographic and clinical union was achieved in 98% of the patients at a mean of 6 months (range, 1 to 24 months). The mean migration of the proximal trochanteric osteotomy fragment prior to union was 3 mm (range, 0 to 29 mm). ETO fragment migration of >1 cm occurred in 7% (37) of the 501 hips that had radiographic analysis. Nine hips (2%) had nonunion of the ETO. Intraoperative fracture of the ETO diaphyseal fragment occurred in 22 hips (4%), postoperative fracture of the ETO diaphyseal fragment occurred in 3 hips (0.5%), and postoperative fracture of the greater trochanter occurred in 41 hips (7%). Survivorship at 10 years free of revision for aseptic femoral loosening, free of femoral or acetabular component removal or revision for any reason, and free of reoperation for any reason was 97%, 91%, and 82%, respectively. Conclusions: This large series of ETOs shows that the union rate is high and clinically important trochanteric migration is infrequent. The most common complications are fracture of the osteotomy fragment intraoperatively or postoperatively. Level of Evidence: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.